Suboxone市场：按类型、剂型、分销管道和地区划分。

2026年，丁丙诺啡市场规模估计为74亿美元，预计2033年将达到96亿美元。预计2026年至2033年，其复合年增长率将达4.1%。

Suboxone是一种处方药，用于抑制阿片类药物（如镇痛药）的作用，从而防止阿片类药物成瘾。 Suboxone可单独使用，也可与其他药物合併使用治疗鸦片类药物成瘾。 Suboxone属于鸦片类拮抗剂、止痛药和鸦片类部分致效剂类药物。 Suboxone由Buprenornhine和纳洛酮组成。Buprenornhine是一种鸦片类药物，有时也被称为麻醉剂。纳洛酮的作用机转是拮抗鸦片类药物的作用，例如镇痛和欣快感，从而预防可能产生的鸦片类药物依赖。

市场动态

预计在预测期内，新上市的丁丙诺啡产品数量的不断增加将推动全球丁丙诺啡市场的成长。 2018年9月，全球製药公司兰尼特公司（Lannett Co Inc.）推出了五款产品，包括Buprenornhine+纳洛酮舌下片。

此外，预计特定地区阿片类药物处方量的增加将在预测期内推动市场成长。例如，2021年11月发表在新的开放取用临床日誌《临床医学》（ClinicalMedicine）上的一项研究发现，儘管全球处方率呈下降趋势，但英国人均处方阿片类药物用于疼痛管理的消费量仍居世界首位。

此外，慢性疼痛盛行率的不断上升预计将在预测期内推动全球丁丙诺啡市场的成长。例如，美国疾病管制与预防中心（CDC）于2018年9月发布的数据显示，2016年美国约有20.4%（5000万人）的成年人患有慢性疼痛，其中8.0%（1960万人）的慢性疼痛严重影响了他们的生活，且患病率老龄化增长而增加。

本报告的主要特点

• 本报告对全球丁丙诺啡市场进行了详细分析，包括预测期（2026-2033 年）的市场规模和复合年增长率，以 2025 年为基准年。
• 此外，它还确定了每个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本文根据以下参数，介绍了全球丁丙诺啡市场主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
• 《全球Suboxon市场》报告面向该行业的众多相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球亚硫酸氢钾市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 抑制因子
  • 市场机会
• 影响分析
• 市场趋势
• 新产品发布
• 法规环境
• PEST分析
• 波特五力分析
• 主要进展
• 品牌分析
• 策略联盟、企业合併

第四章：全球丁丙诺啡市场：按类型划分（2026-2033 年）

• 概述
• 品牌药
• 学名药

第五章 全球丁丙诺啡市场：依剂型划分（2026-2033 年）

• 概述
• 药片
• 电影

第六章：全球Suboxon市场：依通路划分（2026-2033年）

• 概述
• 医院药房
• 零售药房
• 网路药房

第七章 全球丁丙诺啡市场：按地区划分（2026-2033 年）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • GCC
  • 以色列
  • 其他中东国家
• 非洲
  • 北非
  • 中非
  • 南非

第八章 竞争情势

• Indivior PLC.
• Dr. Reddy's Laboratories Ltd.
• Amneal Pharmaceuticals LLC.
• Mylan NV
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Mallinckrodt
• Lannett Co Inc.
• Rhodes Pharmaceuticals LP
• Alvogen
• Sun Pharmaceutical Industries Ltd.
• Alkem Labs
• Hikma Pharmaceuticals PLC

第九章

• 分析方法
• 关于 Coherent Market Insights

Suboxone Market is estimated to be valued at USD 7.4 Bn in 2026 and is expected to reach USD 9.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.

Suboxone is a prescription opioid medication that is used to inhibit the effects of opioid medications, such as pain relief, which can lead to opioid dependence. Suboxone can be used alone or in combination with other drugs to treat opioid addiction. Suboxone belongs to a drug class known as opioid antagonists, analgesics, and opioid partial agonists. Suboxone is composed of buprenorphine and naloxone. Buprenorphine is an opioid medicine, sometimes known as a narcotic. Naloxone counteracts the benefits of opioid medications, such as pain relief and feelings of well-being, which can lead to opioid dependence.

Market Dynamics

The increasing product launches for suboxone is expected to drive the growth of global suboxone market over the forecast period. In September 2018, Lannett Co Inc., a global manufacturer of pharmaceutical products, launched five products that include Buprenorphine plus Naloxone Sublingual tablets, and others.

Moreover, increasing prescription of opioids in certain regions is expected to drive the market growth over the forecast period. For instance, a research published by EclinicalMedicine, a new open access clinical journal, in November 2021 stated that the U.K. had the highest consumption rate of prescription opioids for pain management per capita in the world, despite declining rates globally.

Furthermore, increasing prevalence of chronic pain is expected to drive the growth of global suboxone market over the forecast period. For instance, according to data published by Centers for Disease Control and Prevention in September 2018, stated that an estimated 20.4% of the U.S. adults (50.0 million) had chronic pain and 8.0% of the U.S. adults (19.6 million) had high-impact chronic pain with higher prevalence associated with advancing age in 2016.

Key features of the study

• This report provides an in-depth analysis of the global suboxone market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global suboxone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Indivior PLC, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Rhodes Pharmaceuticals L.P., Alvogen, Sun Pharmaceutical Industries Ltd., Alkem Labs, and Hikma Pharmaceuticals PLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global suboxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global suboxone market

Market Segmentation

• By Type
  • Branded
  • Generics
• By Formulation
  • Tablets
  • Films
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Regional Insights
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Indivior PLC
  • Reddy's Laboratories Ltd.
  • Amneal Pharmaceuticals LLC.
  • Mylan N.V.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Mallinckrodt
  • Lannett Co Inc.
  • Rhodes Pharmaceuticals L.P.
  • Alvogen
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Labs
  • Hikma Pharmaceuticals PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Formulation
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• New Product Launches
• Regulatory Scenario
• PEST Analysis
• PORTER's Analysis
• Key Developments
• Brand Analysis
• Strategic Agreement, Merger And Acquisitions

4. Global Suboxone Market, By Type, 2026 - 2033, (USD Bn)

• Overview
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021-2033
  • Segment Trends
• Branded
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Generics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Suboxone Market, By Formulation, 2026 - 2033, (USD Bn)

• Overview
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021-2033
  • Segment Trends
• Tablets
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Films
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Suboxone Market, By Distribution Channel, 2026 - 2033, (USD Bn)

• Overview
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021-2033
  • Segment Trends
• Hospital pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Suboxone Market, By Region, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Indivior PLC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Dr. Reddy's Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Amneal Pharmaceuticals LLC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mallinckrodt
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lannett Co Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Rhodes Pharmaceuticals L.P.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Alvogen
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Alkem Labs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Hikma Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us